Keeping Pace with the Ever-Changing Pharmaceutical Landscape

Once again, the drug manufacturing sector is in transition; with evermore potent molecules and biologics in the pipeline, can regulators keep pace with the speed of change being driven by the pharmaceutical industry?


LYNNE BYERS | Global Managing Director, Pharmaceuticals and Dietary Supplements Consulting | NSF


KAREN WALKER | Chief Technology Officer | Kyverna Therapeutics
IAN REES | Manager for the Inspectorate Strategy and Innovation Unit | MHRA
KAZEM KAZEMPOUR | President and CEO, Clinical Research Services | Amarex / NSF